Table 1.
Sweet syndrome in patients with and without hematologic malignancy.
| Characteristic | Hematologic malignancy (n = 9) | Without hematologic malignancy (n = 28) | P-value |
|---|---|---|---|
| Age, years | |||
| Mean (SD) | 51 (13) | 54 (12) | 0.560 |
| Median (range) | 52 (24-71) | 53 (28-82) | |
| Female, n (%) | 5 (56) | 16 (57) | 0.933 |
| Fever, n (%) | 7 (78) | 17 (61) | 0.494 |
| Cough/myalgia/fatigue, n (%) | 2 (22) | 6 (21) | 0.958 |
| Arthralgia, n (%) | 0 (0) | 2 (7) | 0.999 |
| Mucosal lesions, n (%) | 3 (33) | 6 (21) | 0.473 |
| Oral ulcers/blisters | 3 (33) | 4 (14%) | |
| Vulvar ulcers | 0 | 1 (4) | |
| Conjunctivitis | 0 | 1 (4) | |
| Generalized lesions, n (%) | 6 (67) | 18 (64) | 1.000 |
| Pain, n (%) | 6 (67) | 15 (54) | 0.637 |
| Pruritus, n (%) | 1 (11) | 8 (29) | 0.267 |
| Laboratory findings | |||
| Hemoglobin [g/L, mean (SD)] | 77.6 (14.0) | 118.0 (24.8) | 0.007 |
| Platelet count [109/L, mean (SD)] | 94.1 (100.8) | 280.4 (137.4) | 0.013 |
| Leukocyte count [109/L, mean (SD)] | 8.8 (7.7) | 9.2 (4.5) | 0.852 |
| Erythrocyte sedimentation rate [mm/h, mean (SD)] | 90.0 (45.7) | 58.2 (34.6) | 0.148 |